Tumor ablation using low-intensity ultrasound and sound excitable drug.

about

Tumor ablation using low-intensity ultrasound and sound excitable drug.

Item

http://www.wikidata.org/entity/Q50239401

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tumor ablation using low-intensity ultrasound and sound excitable drug.

@en

Tumor ablation using low-intensity ultrasound and sound excitable drug.

@nl

type

Item

label

Tumor ablation using low-intensity ultrasound and sound excitable drug.

@en

Tumor ablation using low-intensity ultrasound and sound excitable drug.

@nl

prefLabel

Tumor ablation using low-intensity ultrasound and sound excitable drug.

@en

Tumor ablation using low-intensity ultrasound and sound excitable drug.

@nl

P1476

Tumor ablation using low-intensity ultrasound and sound excitable drug

@en

P2093

Brian E O'Neill

http://www.w3.org/2001/XMLSchema#string

Jianjun Qi

http://www.w3.org/2001/XMLSchema#string

Myung Shin Han

http://www.w3.org/2001/XMLSchema#string

Young Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Using the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers.

A review of low-intensity ultrasound for cancer therapy.

Cancer treatment using an optically inert Rose Bengal derivative combined with pulsed focused ultrasound.

Potentiation of scutellarin on human tongue carcinoma xenograft by low-intensity ultrasound

A frequency-based hypothesis for mechanically targeting and selectively attacking cancer cells.

Development of a Cancer Treatment with the Concomitant Use of Low-Intensity Ultrasound: Entering the Age of Simultaneous Diagnosis and Treatment.

A new sensitizer DVDMS combined with multiple focused ultrasound treatments: an effective antitumor strategy.

Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects.

Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors.

Topical rose bengal: pre-clinical evaluation of pharmacokinetics and safety.

P304

67-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2017.05.009

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

258

http://www.w3.org/2001/XMLSchema#string

P50

Ching-Hsuan Tung

P577

2017-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28499816

http://www.w3.org/2001/XMLSchema#string

P932

5515481

http://www.w3.org/2001/XMLSchema#string